Security Snapshot

NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (NRXP) Institutional Ownership

CUSIP: 629444209

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

31

Shares (Excl. Options)

10.38MFull value: 10,381,867 · shares · 30 Sep 2026

Price

$2.92

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,043,644
Value change
+$5,871,719
Number of holders
31
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
35,443,612
SEC-reported price per share
$2.66
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NRXP - NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 629444209.
  • 31 institutions reported positions in Q3 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 47 to 31 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $47.59MFull value: $47,585,547 · USD · 30 Jun 2026
    to
    $30.29MFull value: $30,293,540 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 31 institutions filings for Q3 2026.

Open SEC evidence

Security key

629444209

13F reference period

Q3 2026

13F holders

31

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
NRXP
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
B Group, Inc. 13% $8,820,000 3,000,000 The B Group, Inc. 18 Aug 2025
Anson Funds Management LP 4.9% -49% $3,855,556 +$292,512 1,736,737 +8.2% Anson Funds Management LP 31 Mar 2026
As of 30 Sep 2026, 31 institutional investors reported holding
10.38MFull value: 10,381,867 · shares · 30 Sep 2026
shares of NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (NRXP). This represents 29% of the company’s total
35.44MFull value: 35,443,612 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
26%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
B Group, Inc. 12% 4,277,200 7.7% $12,489,424
VANGUARD CAPITAL MANAGEMENT LLC 5% 1,789,291 0% $5,224,730
MARSHALL WACE, LLP 2.8% 995,172 0% $2,905,905
COMMONWEALTH EQUITY SERVICES, LLC 1.7% 590,768 0% $1,725,040
GEODE CAPITAL MANAGEMENT, LLC 1.3% 446,457 0% $1,304,406
VANGUARD FIDUCIARY TRUST CO 0.73% 259,798 0% $758,610
STATE STREET CORP 0.35% 125,384 0% $366,121
Prime Capital Investment Advisors, LLC 0.35% 124,631 0% $363,923
Bleakley Financial Group, LLC 0.33% 117,216 0% $342,271
Chicago Partners Investment Group LLC 0.13% 47,542 0% $118,380
One Wealth Management Investment & Advisory Services, LLC 0.13% 45,841 0.11% $133,856
Qube Research & Technologies Ltd 0.11% 39,204 0% $114,476
TWO SIGMA INVESTMENTS, LP 0.09% 31,017 0% $90,570
GROUP ONE TRADING LLC 0.09% 30,143 0% $88,018
Engineers Gate Manager LP 0.06% 22,941 0% $66,988
SBI Securities Co., Ltd. 0.06% 20,001 0% $58,403
TRUIST FINANCIAL CORP 0.06% 20,000 0% $58,400
Vanguard Global Advisers, LLC 0.05% 17,184 0% $50,177
SJBENEN ADVISORY, LLC 0.04% 15,000 0.03% $41,978
Cresset Asset Management, LLC 0.04% 15,000 0% $43,800
Schonfeld Strategic Advisors LLC 0.04% 14,801 0% $43,218
Hudson Bay Capital Management LP 0.04% 12,430 0% $36,296
RENAISSANCE TECHNOLOGIES LLC 0.03% 12,300 0% $35,916
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.03% 12,197 0% $35,615
TWO SIGMA SECURITIES, LLC 0.03% 10,921 0% $31,889

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
10
Headline period
Q3 2026
Rows shown
1-10 of 10
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 10,381,867 $30,293,540 +$5,871,719 $2.92 31
2026 Q2 11,638,886 $47,585,547 +$22,247,954 $4.09 47
2026 Q1 6,204,979 $13,245,594 -$914,787 $2.13 32
2025 Q4 5,235,517 $14,169,868 +$3,242,026 $2.71 28
2025 Q3 3,956,630 $13,043,325 +$3,167,783 $3.30 24
2025 Q2 2,994,368 $9,761,438 +$2,410,566 $3.26 25
2025 Q1 2,260,524 $4,602,262 +$2,464,504 $2.05 22
2024 Q4 1,048,642 $2,306,847 +$754,487 $2.20 25
2024 Q3 714,327 $1,207,232 +$328,214 $1.69 18
2024 Q2 510,346 $1,261,065 +$1,261,065 $2.44 18
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .